SE
Stephen P Ewald (General Counsel & Corp. Secy.) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Medpace Holdings, Inc. (MEDP). The largest single filing was $7.4M of MEDP (16,349 sh × $450.00, as filed), executed May 28. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.2M
shares × price, as filed
Last traded
Oct 29
Filed Nov 2
Median ADV $191.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
MEDPRecent filings
MEDPSALE
Medpace Holdings, Inc.
View filing →
$859K1,245 sh × $690.00
Exec Oct 29
Filed Nov 2 · 6:24 PM ET MEDPSALE Medpace Holdings, Inc. View filing → $7.4M
16,349 sh × $450.00
Exec May 28
Filed Jun 1 · 5:30 PM ET MEDPSALE Medpace Holdings, Inc. View filing → $9.1M
15,230 sh × $598.85
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET MEDPSALE Medpace Holdings, Inc. View filing → $1.4M
3,000 sh × $450.00
Exec Jul 28 2025
Filed Jul 29 2025 · 5:30 PM ET